<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Oral COVID-19 Vaccine Candidate Cleared by FDA
Image Overlay - Oral COVID-19 Vaccine Candidate Cleared by FDA

Oral COVID-19 Vaccine Candidate Cleared by FDA

September 21, 2020

Oral COVID-19 Vaccine Candidate Cleared by FDA

Vaxart, Inc., a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, announced that the U.S. Food and Drug Administration (FDA) had completed its review of the Company’s Investigational New Drug (IND) application for its Phase 1 clinical trial evaluating its oral COVID-19 vaccine candidate. No matter the dosage form, Yourway is prepared to support clinical trials from start to finish.

Back to Index
Media

Upcoming Events

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Global Clinical Trial Innovation, Challenges, and Perspectives

June 6, 2024
Yourway's EU Flagship Depot in Dublin, Ireland

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?